Neuroendocrine and Immune Response to Stress in Schizophrenia
TSST
1 other identifier
interventional
21
1 country
1
Brief Summary
This is a pilot study. We are testing the physiologic, immune and chemical responses to stress. We believe the results of all measures to stress will be blunted in schizophrenia compared to healthy controls. We will test sex, early life stress and other factors on the relationship to a stress response.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable schizophrenia
Started Sep 2013
Longer than P75 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 18, 2013
CompletedFirst Posted
Study publicly available on registry
November 4, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedSeptember 27, 2019
September 1, 2019
4.8 years
October 18, 2013
September 25, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Aim 1) To examine neuroendocrine and physiologic response following a psychosocial stressor in people with schizophrenia and healthy controls.
We will administer the Trier Social Stress Test (TSST) and measure neuroendocrine values (plasma and salivary cortisol and adrenocorticotropic hormone (ACTH) and physiologic variables (heart rate, blood pressure) before during and after the TSST.
1 week
Secondary Outcomes (1)
To investigate neuroimmune and kynurenic acid modulation to a psychosocial stressor in people with schizophrenia and healthy controls
1 week
Study Arms (1)
Trier Social Stress Test
EXPERIMENTALParticipants will participate in a standardized role play (Trier Social Stress Test ). A role play is pretending to be in a certain situation. A research staff member will describe the role play, during which teh participant will act out a scene. Participants will be asked to imagine that they are in a certain role with several other research team members who will also participate in the role play. Participants will also be asked to do some math problems without using paper or pencil.
Interventions
Participants will participate in a standardized role play (Trier Social Stress Test ). A role play is pretending to be in a certain situation. A research staff member will describe the role play, during which teh participant will act out a scene. Participants will be asked to imagine that they are in a certain role with several other research team members who will also participate in the role play. Participants will also be asked to do some math problems without using paper or pencil.
Eligibility Criteria
You may qualify if:
- DSM-IV diagnosis of schizophrenia or schizoaffective disorder (schizophrenia group)
- No DSM-IV Axis I or II disorder (healthy control group)
- Caucasian or Non-Caucasian
You may not qualify if:
- History of Cushing's syndrome, adrenal deficiency, or any condition that may affect cortisol levels in the body.
- Use of steroids
- Pregnancy or lactation. Pregnancy will be determined by urine pregnancy test. Lactation will be determined through patient report.
- Untreated hypertension, cardiac arrthymias or medical condition that could not handle stress.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maryland Psychiatric Research Center
Catonsville, Maryland, 21228, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deanna L Kelly, PharmD, BCPP
University of Maryland, College Park
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pharm.D., BCPP
Study Record Dates
First Submitted
October 18, 2013
First Posted
November 4, 2013
Study Start
September 1, 2013
Primary Completion
June 1, 2018
Study Completion
June 1, 2018
Last Updated
September 27, 2019
Record last verified: 2019-09